fludarabine phosphate has been researched along with Blood Diseases in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cabanillas, F; Dimopoulos, M; Estey, E; Gandhi, V; Kantarjian, H; Keating, MJ; Kemena, A; O'Brien, S; Plunkett, W; Robertson, LE | 1 |
Balcerzak, SP; Benedetti, J; Dakhil, SR; Grever, MR; Miller, TP; Taylor, SA | 1 |
Cabanillas, F; Dimopoulos, M; Gandhi, V; Gregoire, V; Kantarjian, H; Keating, MJ; McLaughlin, P; O'Brien, S; Robertson, LE; Yang, LY | 1 |
Alberts, DS; Green, S; Miller, TP; Stephens, RL; Stock-Novack, DL; Surwit, EA; Von Hoff, DD | 1 |
Carpenter, JT; Raney, M; Vogel, CL; Wang, G | 1 |
2 review(s) available for fludarabine phosphate and Blood Diseases
Article | Year |
---|---|
Fludarabine phosphate: a new active agent in hematologic malignancies.
Topics: Animals; Clinical Trials as Topic; Hematologic Diseases; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Vidarabine Phosphate; Waldenstrom Macroglobulinemia | 1994 |
New initiatives with fludarabine monophosphate in hematologic malignancies.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Hematologic Diseases; Humans; Neoplasms; Remission Induction; Vidarabine Phosphate | 1993 |
3 trial(s) available for fludarabine phosphate and Blood Diseases
Article | Year |
---|---|
A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma.
Topics: Antimetabolites, Antineoplastic; Hematologic Diseases; Humans; Middle Aged; Nausea; Neoplasm Metastasis; Sarcoma; Sleep Stages; Vidarabine Phosphate | 1994 |
Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer. A Southwest Oncology Group Study.
Topics: Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Middle Aged; Uterine Neoplasms; Vidarabine Phosphate | 1991 |
Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trial.
Topics: Antimetabolites, Antineoplastic; Arabinonucleotides; Breast Neoplasms; Clinical Trials as Topic; Drug Evaluation; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Middle Aged; Neoplasm Metastasis; Vidarabine Phosphate | 1986 |